Drugs / Plenum® Guide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06164626 | Dec 2023 → Jun 2024 | — | University of Nove de Julho | Unknown | No outcome recorded |
| Phase 1 | NCT06150456 | May → Aug 2022 | — | University of Nove de Julho | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plenum Guide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06164626 ↗ |
| Modality | Other / unclassified | “Plenum® Guide is a polydioxanone (PDO)-based synthetic membrane material” NCT06150456 ↗ |